ArticleCureus2026
Diagnostic Utility of Mast Cell Density and Neutrophilic Infiltration for Differentiating Aseptic Loosening From Periprosthetic Joint Infection: A Retrospective Cohort Study.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background Accurate differentiation between periprosthetic joint infection (PJI) and aseptic loosening (AL) is essential for appropriate surgical planning and optimal postoperative outcomes. Although neutrophil infiltration remains the standard histological marker for diagnosing PJI, it has recognized limitations. Mast cells, which play a role in chronic inflammatory responses, may serve as a complementary biomarker. This study evaluated the combined diagnostic utility of Giemsa-stained mast cell density and neutrophil counts in periprosthetic tissue to distinguish PJI from AL. Methods This single-center retrospective cohort study included patients who underwent revision arthroplasty between January 2022 and September 2025. PJI was defined according to the 2018 International Consensus Meeting criteria, whereas AL was diagnosed based on negative microbiological cultures and radiographic evidence of loosening. Periprosthetic tissue samples were stained with H&E for neutrophil assessment and Giemsa stain for mast cell identification. Two blinded observers quantified cells across 10 high-power fields (HPFs; 0.237 mm² per field). Results A total of 146 revision cases were analyzed, including 48 PJI and 98 AL cases. Median neutrophil counts were significantly higher in the PJI group than in the AL group (26.5 vs. 1.0 cells/HPF; p < 0.001). Conversely, median mast cell density was significantly higher in AL (11.0 vs. 3.5 cells/HPF; p < 0.001). A neutrophil threshold of ≥5 cells/HPF demonstrated 93.8% sensitivity and 91.8% specificity for diagnosing PJI (area under the curve (AUC) = 0.97). A mast cell cutoff of ≥7 cells/HPF showed 86.7% sensitivity and 85.4% specificity for diagnosing AL (AUC = 0.91). The combined sequential algorithm achieved an overall diagnostic accuracy of 93.2%. Conclusions Giemsa-stained mast cell density is a novel, cost-effective histological marker elevated in AL. When combined with neutrophil counts, it improves diagnostic accuracy and may serve as a practical adjunct in the routine pathological evaluation of revision arthroplasty specimens.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.